MASTER  Workshop: Leading Through Uncertainty: The Human Skills That Drive Success in Global Drug Development.

The project environment in drug development is uniquely complex, highly regulated, and deeply uncertain compared to other sectors. Unlike industries where deliverables follow predictable timelines, drug development operates within a dynamic ecosystem driven by scientific innovation, patient safety, and stringent regulatory requirements. Projects often span years, involve multidisciplinary global teams and require navigating unknowns such as clinical trial outcomes, evolving regulatory landscapes, and market dynamics. Additionally, the stakes are high—delays or missteps can impact patient lives, corporate reputation, and billions of dollars in investment. To navigate this environment, project managers (PMs) must embody critical skills such as strategic foresight, adaptability to shifting priorities, resilience under pressure, and the ability to lead diverse teams with empathy and cultural sensitivity—all uniquely human skills.

Learning goals summary:

Attendees should learn the following by attending the session:

• Demonstrating adaptability in shifting priorities by navigating trade-offs (stage-gate approach).
• Leading diverse teams with empathy and cultural sensitivity by addressing cross-regional challenges (i.e East Asia).
• Fostering resilience to keep teams motivated and purpose-driven in the face of high failure rates, emphasizing how to sustain morale and a sense of shared mission when success feels uncertain.

These examples highlight the essential human elements required to thrive in the unique and demanding landscape of global drug development 

Biography

Christophe de Vleeschouwer offers nearly 30 years of pharmaceutical expertise, excelling in R&D, clinical operations, regulatory transformation, and global asset development. With 15+ years in clinical trials across diverse therapeutic areas, he has advanced from contributor roles to leadership, collaborating with stakeholders like healthcare providers and key opinion leaders. Christophe later transitioned to program management, specializing in transformation initiatives that drive learning agility, lean management, and continuous improvement. His regulatory and global R&D experience highlights his ability to align cross-functional teams and deliver results in complex, high-stakes drug development projects

LinkedIn profile: Christophe De Vleeschouwer